| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±4.5% | +20.6% | under-priced |
| 05/07/2026 | ±4.9% | -12.5% | under-priced |
| 11/10/2025 | ±9.1% | +4.5% | over-priced |
| 08/11/2025 | ±8.8% | +4.6% | over-priced |
| 08/11/2025 | ±8.8% | +4.6% | over-priced |
| 11/10/2025 | ±9.1% | +4.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.07 | $670M | $28M |
| Q1 FY2026 | $0.13 | $647M | $53M |
| Q3 FY2025 | $-0.15 | $544M | $-55M |
| Q2 FY2025 | $-7.29 | $528M | $-923M |
Chime Financial, Inc. Class A Common Stock (CHYM) reports in 7 days, with the next report estimated for 11/04/2026. Across the last 6 reports, options priced an average ±7.5% earnings move while the stock actually moved 8.5% on average — the market has been roughly fair on CHYM's earnings risk. Fundamentals into the print: EPS up 101.0% year-over-year, revenue up 26.8%. QuantLogix's live 5-factor engine currently reads CHYM as a buy at 78/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →